Literature DB >> 2543787

A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens.

K J Fahey1, K Erny, J Crooks.   

Abstract

VP-2b, a major structural protein of infectious bursal disease virus (IBDV), and its precursor protein VP-2a were separated in a soluble form from the supernatant of ultracentrifuged viruses by using a monoclonal antibody specific for VP-3, the other major structural protein, to remove soluble VP-3 and remaining virus particles. The native VP-2a/2b inhibited the majority of virus-neutralizing (VN) activity in chicken anti-IBDV sera and chickens immunized with VP-2a/2b produced VN antibodies that passively protected susceptible chickens from infection. However, the separated VP2a/2b was not as immunogenic as intact virus particles. VP-2a/2b would appear to contain a conformational epitope which is destroyed by SDS and boiling and which may prove to be of critical importance in a subunit vaccine against type 1 IBDV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543787     DOI: 10.1099/0022-1317-70-6-1473

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

1.  Genome assembly and particle maturation of the birnavirus infectious pancreatic necrosis virus.

Authors:  Rodrigo A Villanueva; José L Galaz; Juan A Valdés; Matilde M Jashés; Ana María Sandino
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Full-length sequence analysis of four IBDV strains with different pathogenicities.

Authors:  Daniel Petkov; Erich Linnemann; Darrell R Kapczynski; Holly S Sellers
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

3.  Protective effects of the NLRP3 inflammasome against infectious bursal disease virus replication in DF-1 cells.

Authors:  Zhiyuan He; Yulin Ma; Dongxun Wu; Wenhai Feng; Jin Xiao
Journal:  Arch Virol       Date:  2021-05-12       Impact factor: 2.574

4.  Molecular epizootiology of infectious bursal disease (IBD) in Korea.

Authors:  Woo-Jin Jeon; Kang-Seuk Choi; Dong-Woo Lee; Eun-Kyoung Lee; Sang-Ho Cha; Sun-Hee Cho; Jun-Hun Kwon; Yeo-sung Yoon; Sun-Joong Kim; Jae-Hong Kim; Hyuk-Joon Kwon
Journal:  Virus Genes       Date:  2009-09-01       Impact factor: 2.332

Review 5.  Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

Authors:  M M Nagarajan; F S Kibenge
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

6.  C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Authors:  J R Castón; J L Martínez-Torrecuadrada; A Maraver; E Lombardo; J F Rodríguez; J I Casal; J L Carrascosa
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines.

Authors:  Yakhya Dieye; Arjan J W Hoekman; Florence Clier; Vincent Juillard; Hein J Boot; Jean-Christophe Piard
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

9.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-gamma.

Authors:  Jeong Ho Park; Haan Woo Sung; Byung Il Yoon; Hyuk Moo Kwon
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.